|
|
Volumn 25, Issue 22, 2004, Pages 1974-1978
|
|
The data monitoring experience in the MOXCON trial
a
|
|
Author keywords
Data monitoring; Decision making; Heart failure; Mortality; Randomized controlled trial
|
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
MOXONIDINE;
NORADRENALIN;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DATA ANALYSIS;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
FOLLOW UP;
HUMAN;
HYPOTENSION;
KIDNEY DISEASE;
LOW DRUG DOSE;
METHODOLOGY;
MORTALITY;
PATIENT MONITORING;
PRIORITY JOURNAL;
RANDOMIZATION;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SUSTAINED DRUG RELEASE;
CLINICAL TRIALS DATA MONITORING COMMITTEES;
DECISION MAKING;
HEART FAILURE, CONGESTIVE;
HUMANS;
IMIDAZOLES;
PUBLISHING;
RANDOMIZED CONTROLLED TRIALS;
RISK FACTORS;
SYMPATHOLYTICS;
|
|
EID: 8444244421
PISSN: 0195668X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ehj.2004.09.015 Document Type: Review |
|
Times cited : (33)
|
|
References (7)
|
